11，Coplen SE,Antman EM,Berlin JA,etal.Efficacy and safety of quinidine therapy for maintenance of sinus rhythm aftercardioversion.A meta-analysis of radomized controlled trials.Circulation,1990,82∶1106-1116.
22，Reinmold SC,Cantillon CO,Friedman PL,et al.Propafenone versus sotalol for suppressionof recurrent symptomatic atrial fibrillation.Am J Cardiol,1993,71∶558-563.
33，Falk RH.Flecainide-induced ventricular tachycardia and fibrillation in patientstreated for atrial fibrillation.Ann Intern Med,1989,111∶107-111.
44，De Simorie A,Stabile G,Vital DF,et al.Pretreatment with verapamil in patients withpersistent or chronic atrial fibrillation who underwent electrical conversion.J Am CollCardiol,1999,34∶810-815.
55，Blevins RD,Kerin NZ,Benaderet D,et al.Amiodarone in the management of refractoryatrial fibrillation.Arch Intern Med,1987,147∶1401-1404.
66，Brodsky MA,Allen BJ,Walker CJ,et al.Amiodarone for maintenance of sinus rhythm afterconversion of atrial fibrillation in the setting of a dilated left atrium.Am JCardiol,1987,60∶572-575.
77，Gosselink ATM,Crijns HJGM,van Gelder IC,et al.Low-dose amiodarone for maintenance ofsinus rhythm after cardioversion of atrial fibrillation or flutter.JAMA,1992,267∶3289-3293.
88，Chun SH,Sager PT,Stevenson WG,et al.Long-term efficacy of amiodarone for themaintenance of normal sinus rhythm in patients with refractory atrial fibrillation orflutter.Am J Cardiol,1995,76∶47-50.
99，Gold RL,Haffajee CI,Charos G,et al.Amiodarone for refractory atrial fibrillation.Am JCardiol,1986,57∶124-127.
1010，Hohnloser SH,Klingenheben T,Singh BN.Amiodarone-associated proarrhythmic effects.Areview with special reference to torsade de pointes tachycardia.Ann Intern Med,1994,121∶529-535.
